Skip to main content
SpringerLink
Log in

Prediction of outcome to a second trial of antidepressant medications following nonremission with citalopram therapy

  • Clinical Trials Report
  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  1. Rush AJ, Trivedi MH, Wisniewski SR, et al.; STAR*D Study Team: Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 2006, 354:1231–1242.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Michael E. Thase
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thase, M.E. Prediction of outcome to a second trial of antidepressant medications following nonremission with citalopram therapy. Curr Psychiatry Rep 10, 449–451 (2008). https://doi.org/10.1007/s11920-008-0072-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-008-0072-8

Keywords

Search

Navigation